FDA has approved the PreciseType HEA test by Immucor as the first agency-approved molecular assay to generate genetic matching information for use in blood banking and transfusion medicine to prevent alloimmunization and transfusion reactions.
Read More
Molecular diagnostics company OpGen Inc has launched a molecular-based test that can quickly and reliably identify patients at risk for harboring serious disease-causing microbes that can resist even the strongest antibiotics.
Read More
A recent report by the World Health Organization (WHO) indicates that every region of the world is headed rapidly toward a “post-antibiotic era,” in which even common infections and minor injuries can kill.
Read More
Molecular diagnostics company Diagnovus and Cincinnati Children’s Hospital Medical Center are partnering to commercialize the first genomic assay to help physicians diagnose and treat eosinophilic esophagitis, a debilitating inflammatory condition.
Read More
Vermillion, a diagnostics company focused on gynecologic cancers and women’s health, has launched Aspira Labs, which will specialize in applying biomarker-based technologies for the management of gynecologic cancers.
Read More